Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(360) A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C